G8F-11807-99303
2 vaccinations
7 coded responses
25 check-ins
7 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 967 / HI
- Registered
- 2021-08-21
- Relationship
- Self
- Race
- Asian
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-08-21
Registered in v-safe
-
2021-08-21
Dose 1 — Moderna
- 2021-08-21
- 2021-08-22
-
2021-08-23
Health check-in — days 1–6 daily, dose 1Feeling: Good · Rash, not including the immediate area around the injection siteAdult check-in
-
2021-08-24
Survey response — days 1–6 daily, dose 1MedDRA: Musculoskeletal pain, Pain — Feeling: GoodFree text: Pain in shoulder blade with movementMedDRA releases: 2021-09,2024-11 · check-in free text available
- 2021-08-25
- 2021-08-26
- 2021-08-27
- 2021-08-28
- 2021-09-04
- 2021-09-11
-
2021-09-18
Dose 2 — Moderna
- 2021-09-18
-
2021-09-20
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Redness · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Rash, not including the immediate area around the injection siteAdult check-in
-
2021-09-21
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Redness, Itching · Headache, Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-09-22
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Redness, Itching · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-09-23
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-09-24
- 2021-09-25
-
2021-10-02
Survey response — day 14, dose 2MedDRA: Headache — Feeling: GoodFree text: HeadachesMedDRA releases: 2024-11 · check-in free text available
- 2021-10-11
- 2021-10-16
-
2021-10-23
Survey response — day 35, dose 2MedDRA: Heart rate increased — Feeling: GoodFree text: Increased heart rateMedDRA releases: 2024-11 · check-in free text available
-
2021-10-30
Survey response — day 42, dose 2MedDRA: Unevaluable event — Feeling: Poor · Be unable to do your normal daily activitiesFree text: Painful menstrual cramps.MedDRA releases: 2024-11 · check-in free text available
-
2021-12-18
Survey response — 3 months, dose 2MedDRA: Dysmenorrhoea, Heavy menstrual bleeding, Ovarian cyst ruptured — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visitFree text: Ruptured ovarian cysts & heavier menstrual flow & increased menstrual cramps.MedDRA releases: 2024-11 · check-in free text available
-
2021-12-18
Report sent to call center — 3 months, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalEmergency room or emergency department visit · 1 call case(s)
- 2021-12-20
-
2022-03-19
Survey response — 6 months, dose 2MedDRA: Dysmenorrhoea, Heavy menstrual bleeding, Ovarian cyst ruptured, Uterine leiomyoma, Uterine polyp — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visitFree text: Ovarian cysts ruptured, uterine fibroids and polyps. Heavy menstruation and painful cramping.MedDRA releases: 2024-11 · check-in free text available
-
2022-03-19
Report sent to call center — 6 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
- 2022-03-22
-
2022-09-18
Survey response — 12 months, dose 2MedDRA: Autoimmune thyroiditis, Graves' disease — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Graves disease Hashimotos diseaseMedDRA releases: 2024-11 · check-in free text available
-
2022-09-18
Report sent to call center — 12 months, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-09-19
- 2022-09-19
- 2022-09-19
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-08-21 | Moderna | No |
| 2 | 2021-09-18 | Moderna | No |
Call center
3 call center cases
3 unsuccessful
Free text
Release 9 — days 1–6 daily, dose 1
Systemic reaction (other): Pain in shoulder blade with movement
Release 9 — day 14, dose 2
Symptoms: Headaches
Release 10 — day 35, dose 2
Symptoms: Increased heart rate
Release 10 — day 42, dose 2
Symptoms: Painful menstrual cramps.
Release 10 — 3 months, dose 2
Symptoms: Ruptured ovarian cysts & heavier menstrual flow & increased menstrual cramps.
Release 11 — 6 months, dose 2
Symptoms: Ovarian cysts ruptured, uterine fibroids and polyps. Heavy menstruation and painful cramping.
Release 12 — 12 months, dose 2
Symptoms: Graves disease Hashimotos disease
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Autoimmune thyroiditis | · | · | ✓ |
| SD | Dysmenorrhoea | · | · | ✓ |
| SD | Graves' disease | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Heart rate increased | · | · | ✓ |
| SD | Heavy menstrual bleeding | · | · | ✓ |
| SD | Ovarian cyst ruptured | · | · | ✓ |
| SD | Unevaluable event | · | · | ✓ |
| SD | Uterine leiomyoma | · | · | ✓ |
| SD | Uterine polyp | · | · | ✓ |
| SRO | Musculoskeletal pain | ✓ | · | ✓ |
| SRO | Pain | ✓ | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release